Here, the EZ MHC-I assay for HLA-A*11:01 has identified a set of 14 stabilizing peptides with varying NetMHCpan ranks derived from key EGFR mutations associated with non-small cell lung cancer (NSCLC). This evidence concerns the gene EGFR and non-small cell lung carcinoma.